Maryland Capital Management Becton Dickinson & CO Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Maryland Capital Management holds 1,957 shares of BDX stock, worth $447,154. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,957

Previous 1,957 -0.0%

Holding current value

$447,154

Previous $482,000 9.54%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $4,421 - $4,872	-19 Reduced 0.96%	1,957 $481,000
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $21,403 - $23,421	-92 Reduced 4.45%	1,976 $481,000
Q1 2021 May 11, 2021	BUY	$232.09 - $256.88 $479,962 - $531,227	2,068 New	2,068 $503,000
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $186,425 - $239,120	-864 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$219.9 - $263.41 $189,993 - $227,586	864 New	864 $207,000
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $12.5 Million - $17.8 Million	-63,789 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$236.45 - $266.82 $192,943 - $217,725	816 Added 1.3%	63,789 $17.3 Million
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $384,838 - $427,397	1,669 Added 2.72%	62,973 $15.9 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $301,533 - $341,312	1,387 Added 2.31%	61,304 $15.4 Million
Q1 2019 May 13, 2019	BUY	$206.05 - $248.17 $622,889 - $750,217	3,023 Added 5.31%	59,917 $15 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $11.5 Million - $14.5 Million	56,033 Added 6507.9%	56,894 $12.8 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $179,174 - $201,344	861 New	861 $206,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Becton Dickinson & CO Transaction History